Tuning the Anticancer Activity of Gold(I) Complexes via Redox-Active Ar-Bian Ligands: Experimental and Theoretical Insights
Inorganic Chemistry · 12.10.2026 · 65 (40) · 23404-23423
DOI: 10.1021/acs.inorgchem.6c02443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, online erschienen am 03.09.2026. Verfasst von Nikolay O Shaposhnikov und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nikolaev Institute of Inorganic Chemistry SB RAS, Novosibirsk630090, Russia. Hauptthemen laut MEDLINE: Antineoplastic Agents, Gold, Coordination Complexes, Density Functional Theory. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
A series of cationic gold(I) complexes of the type [Au(PPh3)(Ar-Bian)](CF3SO3) based on 1,2-bis[(2,4,6-trimethylphenyl)imino]acenaphthene (tmp-Bian), 1,2-bis[(4-chlorophenyl)imino]acenaphthene (4–Cl-C6H4–Bian), 1,2-bis[(4-bromophenyl)imino]acenaphthene (4–Br-C6H4–Bian), and 1,2-bis[(4-iodophenyl)imino]acenaphthene (4–I-C6H4–Bian) were prepared. All complexes were fully characterized by spectrochemical methods, and their crystal structures were established by X-ray diffraction analysis. The electrochemical behavior of all complexes was studied by using cyclic voltammetry. The stability of the complexes in solution was investigated using 1H NMR and UV–vis spectroscopies. The anticancer activity of Au(I) complexes was evaluated against a panel of cell lines in comparison with free 1,2-bis(arylimino)aceaphthenes (Ar-Bian) and initial [Au(PPh3)Cl]. All complexes were cytotoxic in a low micromolar range and showed selectivity toward cancer cells in comparison with MRC-5 human lung fibroblasts. The ability of the complexes to bind DNA and BSA was investigated by spectroscopic methods, molecular docking, and molecular dynamics studies. The DNA-damaging activity of gold(I) complexes was evaluated in MCF-7 cells using the comet assay. Reactive oxygen species production in MCF-7 cells was studied using confocal microscopy. The lipophilicity of complexes was determined using the n-octanol/water shake-flask method. Determination of the cell death pathway was performed using an Annexin-5-FITC/PI double staining test followed by fluorescence-activated cell sorting (FACS) analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nikolaev Institute of Inorganic Chemistry SB RAS, Novosibirsk630090, Russia.
- Department of Natural Sciences, Novosibirsk State University, Novosibirsk630090, Russia.
ORCID-Profile: Michael A Shestopalov, Artem L Gushchin
Förderung
- Russian Science Foundation
Zitieren
APA
Shaposhnikov, N. O., Korotkova, S. V., Komlyagina, V. I., Bakaev, I. V., Ulantikov, A. A., Klimina, K. V., Yakovlev, I. A., Kuratieva, N. V., Kompankov, N. B., Fomenko, I. S., Kharlamova, V. Y., Shestopalov, M. A., Romashev, N. F., & Gushchin, A. L. (2026). Tuning the Anticancer Activity of Gold(I) Complexes via Redox-Active Ar-Bian Ligands: Experimental and Theoretical Insights. Inorganic Chemistry, 65(40), 23404-23423. https://doi.org/10.1021/acs.inorgchem.6c02443
Vancouver
Shaposhnikov NO, Korotkova SV, Komlyagina VI, Bakaev IV, Ulantikov AA, Klimina KV, et al. Tuning the Anticancer Activity of Gold(I) Complexes via Redox-Active Ar-Bian Ligands: Experimental and Theoretical Insights. Inorganic Chemistry. 2026;65(40):23404-23423. doi:10.1021/acs.inorgchem.6c02443
BibTeX
@article{Shaposhnikov2026,
author = {Shaposhnikov, Nikolay O and Korotkova, Sofia V and Komlyagina, Veronika I and Bakaev, Ivan V and Ulantikov, Anton A and Klimina, Katerina V and Yakovlev, Ivan A and Kuratieva, Natalia V and Kompankov, Nikolay B and Fomenko, Iakov S and Kharlamova, Viktoria Yu and Shestopalov, Michael A and Romashev, Nikolai F and Gushchin, Artem L},
title = {Tuning the Anticancer Activity of Gold(I) Complexes via Redox-Active Ar-Bian Ligands: Experimental and Theoretical Insights},
journal = {Inorganic Chemistry},
year = {2026},
volume = {65},
number = {40},
pages = {23404--23423},
doi = {10.1021/acs.inorgchem.6c02443}
}
EUVIMED